These pathologic conditions, generally called amyloidosis, include neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease, Corea of Hungtington, Type II Diabetes Mellitus, and systemic diseases like immunoglobulin light chain, transthyretin and dialysis-related amyloidosis. This evidence concerns the gene TTR and Parkinson disease.